Pancreatic Cancer Patients May Harbor Treatable Germline Mutations Pancreatic Cancer Patients May Harbor Treatable Germline Mutations

Germline mutations commonly found in individuals with pancreatic ductal adenocarcinoma (PDAC) may be treatable and should be identified as soon as possible, a comprehensive review suggests.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news